Viral Hepatitis

In this episode of Beyond Substance podcast, Jason Rush shares his journey through addiction and hepatitis C, while Dr. Janet Arno provides expert insight on treatment and public health solutions.

In this podcast episode, Anousha and Bright invited Dr. Robert Gish to speak about hepatitis B Reactivation, a serious health issue often overlooked in the discourse surrounding hepatitis B and liver cancer.

NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 2: Part 2: Current Methadone Access: Where are we now?” webinar on September 24 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C transmission among people who inject drugs. NCLM advocates for a more accessible and equitable methadone system that prioritizes patient health, promotes dignity, and is grounded in evidence.

This toolkit is designed for new viral hepatitis health department staff to help them get oriented in their new role. It includes basic information, recommendations, key national partners, CDC funding opportunities, and where to go for help.

NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 1: History of the Methadone System: How did we get here?” webinar on September 11 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C transmission among people who inject drugs. NCLM advocates for a more accessible and equitable methadone system that prioritizes patient health, promotes dignity, and is grounded in evidence.

NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 1: History of the Methadone System: How did we get here?” webinar on September 11 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C transmission among people who inject drugs. NCLM advocates for a more accessible and equitable methadone system that prioritizes patient health, promotes dignity, and is grounded in evidence.

The National Health and Nutrition Examination Survey (NHANES) underestimates the true prevalence of hepatitis C virus (HCV) infection in the U.S. due to inadequate representation of certain populations. Two models were developed to provide more accurate estimates of HCV prevalence among U.S. adults from 2017 to 2020.

This webinar recording features updates on new hepatitis C prevalence estimates.